UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 158

Sortiert nach

Iron uptake in quiescent and inflammation-activated astrocytes: A potentially neuroprotective control of iron burden

Biochimica et biophysica acta, 2013-08, Vol.1832 (8), p.1326-1333

2013

Volltextzugriff (PDF)

Polarization dictates iron handling by inflammatory and alternatively activated macrophages

Haematologica (Roma), 2010-11, Vol.95 (11), p.1814-1822

2010

Volltextzugriff (PDF)

Bmp6 expression in murine liver non parenchymal cells: a mechanism to control their high iron exporter activity and protect hepatocytes from iron overload?

PloS one, 2015-04, Vol.10 (4), p.e0122696-e0122696

2015

Volltextzugriff (PDF)

The human counterpart of zebrafish shiraz shows sideroblastic-like microcytic anemia and iron overload

Blood, 2007-08, Vol.110 (4), p.1353-1358

2007

Volltextzugriff (PDF)

Iron Causes Lipid Oxidation and Inhibits Proteasome Function in Multiple Myeloma Cells: A Proof of Concept for Novel Combination Therapies

Cancers, 2020-04, Vol.12 (4), p.970

2020

Volltextzugriff (PDF)

Ceruloplasmin oxidation, a feature of Parkinson's disease CSF, inhibits ferroxidase activity and promotes cellular iron retention

The Journal of neuroscience, 2011-12, Vol.31 (50), p.18568-18577

2011

Volltextzugriff (PDF)

Oxidative stress and cell death in cells expressing L-ferritin variants causing neuroferritinopathy

Neurobiology of disease, 2010-01, Vol.37 (1), p.77-85

2010

Volltextzugriff (PDF)

Iron increases the susceptibility of multiple myeloma cells to bortezomib

Haematologica (Roma), 2013-06, Vol.98 (6), p.971-979

2013

Volltextzugriff (PDF)

Identification of TMPRSS6 cleavage sites of hemojuvelin

Journal of cellular and molecular medicine, 2015-04, Vol.19 (4), p.879-888

2015

Volltextzugriff (PDF)

P1225: CYLD, A NOVEL REGULATOR OF SPLENIC MARGINAL ZONE LYMPHOMA PATHOGENESIS

HemaSphere, 2023-08, Vol.7 (S3), p.e1177106-n/a

2023

Volltextzugriff (PDF)

P1489: HIGH DOSE IRON IMPAIRS MALIGNANT B‐CELL VIABILITY AND IMPROVES IMMUNE ANTITUMOR FUNCTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA

HemaSphere, 2023-08, Vol.7 (S3), p.e6299789-n/a

2023

Volltextzugriff (PDF)

Pantothenate kinase-2 (Pank2) silencing causes cell growth reduction, cell-specific ferroportin upregulation and iron deregulation

Neurobiology of disease, 2010-08, Vol.39 (2), p.204-210

2010

Volltextzugriff (PDF)

P1517: HUMORAL AND CELLULAR IMMUNE RESPONSES TO SARS‐COV‐2 NATURAL INFECTION OR VACCINATION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A STUDY BY ERIC, THE EUROPEAN RESEARCH INITIATIVE ON CLL

HemaSphere, 2023-08, Vol.7 (S3), p.e483427a-n/a

2023

Volltextzugriff (PDF)

Over-expression of mitochondrial ferritin affects the JAK2/STAT5 pathway in K562 cells and causes mitochondrial iron accumulation

Haematologica (Roma), 2011-10, Vol.96 (10), p.1424-1432

2011

Volltextzugriff (PDF)

Human Mitochondrial Ferritin Expressed in HeLa Cells Incorporates Iron and Affects Cellular Iron Metabolism

The Journal of biological chemistry, 2002-06, Vol.277 (25), p.22430-22437

2002

Volltextzugriff (PDF)

Characterization of the l-ferritin variant 460InsA responsible of a hereditary ferritinopathy disorder

Neurobiology of disease, 2006-09, Vol.23 (3), p.644-652

2006

Volltextzugriff (PDF)

Loss of the von Hippel Lindau Tumor Suppressor Disrupts Iron Homeostasis in Renal Carcinoma Cells

The Journal of biological chemistry, 2005-08, Vol.280 (34), p.30120-30128

2005

Volltextzugriff (PDF)

Iron Induces Cell Death and Strengthens the Efficacy of Antiandrogen Therapy in Prostate Cancer Models

Clinical cancer research, 2020-12, Vol.26 (23), p.6387-6398

2020

Volltextzugriff (PDF)

Bone marrow Tfr2 deletion improves the therapeutic efficacy of the activin‐receptor ligand trap RAP‐536 in β‐thalassemic mice

American journal of hematology, 2024-07, Vol.99 (7), p.1313-1325

2024

Volltextzugriff (PDF)

Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice

Blood, 2016-05, Vol.127 (19), p.2327-2336

2016

Volltextzugriff (PDF)

Mitochondrial ferritin limits oxidative damage regulating mitochondrial iron availability: hypothesis for a protective role in Friedreich ataxia

Human molecular genetics, 2009-01, Vol.18 (1), p.1-11

2009

Volltextzugriff (PDF)

Inhibiting the Immunophilin FKBP12: A Potential Therapeutic Approach to Iron Overload/Low Hepcidin Disorders

Blood, 2018-11, Vol.132 (Supplement 1), p.2333-2333

2018

Volltextzugriff (PDF)

CLL-461 Humoral Response to COVID-19 Vaccine: A Challenge in CLL

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22, p.S279-S280

2022

Volltextzugriff (PDF)

Poster: CLL-461 Humoral Response to COVID-19 Vaccine: A Challenge in CLL

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22, p.S143-S143

2022

Volltextzugriff (PDF)

1 – 25 von 158

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(143)
Mit Volltextzugriff
(144)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Iron uptake in quiescent and inflammation-activated astrocytes: A potentially neuroprotective control of iron burden

Polarization dictates iron handling by inflammatory and alternatively activated macrophages

Bmp6 expression in murine liver non parenchymal cells: a mechanism to control their high iron exporter activity and protect hepatocytes from iron overload?

The human counterpart of zebrafish shiraz shows sideroblastic-like microcytic anemia and iron overload

Iron Causes Lipid Oxidation and Inhibits Proteasome Function in Multiple Myeloma Cells: A Proof of Concept for Novel Combination Therapies

Ceruloplasmin oxidation, a feature of Parkinson's disease CSF, inhibits ferroxidase activity and promotes cellular iron retention

Oxidative stress and cell death in cells expressing L-ferritin variants causing neuroferritinopathy

Iron increases the susceptibility of multiple myeloma cells to bortezomib

Identification of TMPRSS6 cleavage sites of hemojuvelin

P1225: CYLD, A NOVEL REGULATOR OF SPLENIC MARGINAL ZONE LYMPHOMA PATHOGENESIS

P1489: HIGH DOSE IRON IMPAIRS MALIGNANT B‐CELL VIABILITY AND IMPROVES IMMUNE ANTITUMOR FUNCTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA

Pantothenate kinase-2 (Pank2) silencing causes cell growth reduction, cell-specific ferroportin upregulation and iron deregulation

P1517: HUMORAL AND CELLULAR IMMUNE RESPONSES TO SARS‐COV‐2 NATURAL INFECTION OR VACCINATION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A STUDY BY ERIC, THE EUROPEAN RESEARCH INITIATIVE ON CLL

Over-expression of mitochondrial ferritin affects the JAK2/STAT5 pathway in K562 cells and causes mitochondrial iron accumulation

Human Mitochondrial Ferritin Expressed in HeLa Cells Incorporates Iron and Affects Cellular Iron Metabolism

Characterization of the l-ferritin variant 460InsA responsible of a hereditary ferritinopathy disorder

Loss of the von Hippel Lindau Tumor Suppressor Disrupts Iron Homeostasis in Renal Carcinoma Cells

Iron Induces Cell Death and Strengthens the Efficacy of Antiandrogen Therapy in Prostate Cancer Models

Bone marrow Tfr2 deletion improves the therapeutic efficacy of the activin‐receptor ligand trap RAP‐536 in β‐thalassemic mice

Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice

Mitochondrial ferritin limits oxidative damage regulating mitochondrial iron availability: hypothesis for a protective role in Friedreich ataxia

IκBε deficiency accelerates disease development in chronic lymphocytic leukemia

Inhibiting the Immunophilin FKBP12: A Potential Therapeutic Approach to Iron Overload/Low Hepcidin Disorders

CLL-461 Humoral Response to COVID-19 Vaccine: A Challenge in CLL

Poster: CLL-461 Humoral Response to COVID-19 Vaccine: A Challenge in CLL

Suchergebnisse filtern